A 96-year-old woman with inherited type 2A von Willebrand disease and previously mild symptoms experienced a sudden worsening of bleeding after developing acquired von…
People with congenital thrombotic thrombocytopenic purpura (cTTP) face a substantial burden related to healthcare use and costs, particularly for inpatient admissions directly related to the disease, according to a real-world study in England. The study demonstrated that almost 40% of patients experienced an acute TTP episode during follow-up periods…
Latest news & perspectives
Adding Cablivi (caplacizumab-yhdp) to standard treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) may help protect the brain by repairing damage to the blood-brain barrier,…
Blocking the activity of an enzyme known as MELK may help boost the production of platelets — tiny cell fragments that improve blood clotting and…
